What Will it Take to Address the Global Threat of Antibiotic Resistance?

Hammarskjöld Foundation D. , “Who We Are,” available at <http://www.daghammarskjold.se/who-we-are> (last visited June 10, 2015).

Global Strategy Lab, “Mission,” available at <http://www.globalstrategy.ninja/about> (last visited June 10, 2015).

American Society of Law, Medicine & Ethics, Journal of Law, Medicine & Ethics , “Back Issues and Articles,” available at <http://www.aslme.org/Back_Issues_And_Articles?journal=JLME> (last visited June 10, 2015).

Norwegian Institute of Public Health, “Better Health for All,” available at <http://www.fhi.no/eway/?pid=240> (last visited June 10, 2015).

ReAct – Action on Antibiotic Resistance, “Who We Are,” available at <http://www.reactgroup.org/who-we-are.html> (last visited June 10, 2015).

Barlam T. F. Gupta K. , “Antibiotic Resistance Spreads Across Borders,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.

Hoffman S. J. Outterson K. Røttingen J.-A. Cars O. Clift C. Rizvi Z. , “An International Legal Framework to Address Antimicrobial Resistance,” Bulletin of the World Health Organization 93, no. 2 (2015): 66.

Daulaire N. Bang A. Tomson G. Kalyango J. N. Cars O. , “Universal Access to Effective Antimicrobials: An Essential Feature of Global Collective Action against Antimicrobial Resistance,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.

Review on Antimicrobial Resistance, “Tackling Drug-Resistant Infections Globally,” available at <http://amr-review.org/home> (last visited June 11, 2015).

Clift C. Gopinathan U. Morel C. Outterson K. Røttingen J.-A. So A. D. , Towards a New Global Business Model for Antibiotics: Report from the Chatham House Working Group on New Antibiotic Business Models (Chatham House, 2015).

World Health Organization: Draft Global Action Plan on Antimicrobial Resistance, World Health Organization, available at <http://www.who.int/drugresistance/AMR_DRAFT_GAP_1_Oct_2014_for_MS_consultation.pdf> (last visited June 11, 2015).

Outterson K. Powers J. H. Daniels G. W. McClellan M. B. , “Repairing the Broken Market for Antibiotic Innovation,” Health Affairs 34, no. 2 (2015): 277–285.

Balasegaram M. Clift C. Røttingen J.-A. , “A Pathway towards an Alternative Business Model for Antibiotic Innovation: A Framework, Fund and Institutional Mechanism,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.

Podolsky S. H. Bud R. Gradmann C. Hobaek B. Kirchhelle C. Mitvedt T. Santesmases M. J. Thoms U. Berild D. Kveim Lie A. , “History Teaches Us That Confronting Antibiotic Resistance Requires Stronger Global Collective Action,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.

Hollis A. Maybarduk P. , “Antibiotic Resistance Is a Tragedy of the Commons That Necessitates Global Cooperation,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.

So A. D. Shah T. A. Roach S. Chee Y. L. Nachman K. E. , “International Agreement to Address the Contribution of Animal Agriculture to Antibiotic Resistance: A One Health Approach,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.

Andresen S. Hoffman S. J. , “Much Can Be Learned about Addressing Antibiotic Resistance from Multilateral Environmental Agreements,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.

Ottersen T. Hoffman S. J. , “Addressing Antibiotic Resistance Requires Robust International Accountability Mechanisms,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.

Hoffman S. J. Røttingen J.-A. Frenk J. , “International Law Has a Role to Play in Addressing Antibiotic Resistance,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.

Hoffman S. J. Røttingen J.-A. , “A Framework Convention on Obesity Control?” The Lancet 378, no. 9809 (2011): 2068; Hoffman S. J. Røttingen J.-A. , “Be Sparing With International Laws,” Nature 483, no. 7389 (2012): 275; Hoffman S. J. Røttingen J.-A. , “Dark Sides of the Proposed Framework Convention on Global Health's Many Virtues: A Systematic Review and Critical Analysis,” Health and Human Rights 15, no. 1 (2013): E117–E134; Hoffman S. J. Røttingen J.-A. , “Assessing the Expected Impact of Global Health Treaties: Evidence from 90 Quantitative Evaluations,” American Journal of Public Health 105, no. 1 (2015): 26–40; Hoffman S. J. Røttingen J.-A. Frenk J. , “Assessing Proposals for New Global Health Treaties: An Analytic Framework,” American Journal of Public Health (2015): e1–e8.

See Hoffman Røttingen Frenk , supra note 20.

Behdinan A. Hoffman S. J. Pearcey M. , “Some Global Policies for Antibiotic Resistance Depend on Legally Binding and Enforceable Commitments,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.

Rizvi Z. Hoffman S. J. , “Effective Global Action on Antibiotic Resistance Requires Careful Consideration of Convening Forums,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.

Hoffman S. J. , “A Science of Global Strategy,” in Frenk J. Hoffman S. J. , eds., “To Save Humanity”: What Matters Most for a Healthy Future (New York: Oxford University Press, 2015): At 173–175.

ReAct – Action on Antibiotic Resistance, “Royal Recognition and New Antibiotics Center Confirmed,” available at <http://www.reactgroup.org/news/496/18.html> (last visited June 10, 2015).